First human trial for experimental Marburg virus vaccine reports success

Promising results have been published from the first human trial testing an experimental vaccine targeting the deadly Marburg virus. Flagged as a potential pandemic-causing virus, this is the first Marburg vaccine to move into Phase 2 human trials.

Related Keywords

Angola ,Kenya ,United States ,Democratic Republic Of The Congo ,Uganda ,Ghana ,Daniela Manno ,London School Of Hygiene ,Democratic Republic ,London School ,Tropical Medicine ,